News

In a report released on July 30, Nicolas Pauillac from Kepler Capital maintained a Hold rating on GlaxoSmithKline, with a price target of p1,500.00. The company’s shares closed yesterday at p1,418.00.
In the aftermath of the 1971 Liberation War, newly sovereign Bangladesh inherited little industrial infrastructure.
DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Sanofi today. The company’s shares opened today at $91.00. Elevate Your Investing Strategy: Take advantage of TipRanks ...
Caleb University, Imota, Lagos, is set to host the second edition of its employability fair on August 4 and 5, 2025, as part of efforts to bridge the gap between academic knowledge and real-world ...
He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...
Over 100 employees from GSK’s Hamilton site recently rolled up their sleeves for their annual "Together Days," a volunteer ...
Just hours before the midnight deadline, the White House unveiled its updated trade policy, reaffirming a 10% "universal" ...
President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...
Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...
DONALD Trump insists he will unleash “every tool in our arsenal” if British drug companies don’t cut their prices within 60 ...
Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...